NCT05257382

Brief Summary

A monocentric prospective and randomized trial aiming to compare the diagnostic yield and safety of electromagnetical-guided bronchoscopy (ENB) procedures coupled to trans-bronchial lung cryobiopsies for the diagnosis of pulmonary nodule when performed either in a "standard" bronchoscopy suite or in a hybrid room with CBCT guidance and the use of the CrossCountry technique as required.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for not_applicable lung-cancer

Timeline
Completed

Started Feb 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2020

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

February 8, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 25, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2022

Completed
Last Updated

July 27, 2022

Status Verified

July 1, 2022

Enrollment Period

2.2 years

First QC Date

February 8, 2022

Last Update Submit

July 25, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diagnostic yield

    The primary outcome will be the comparison of the diagnostic yield obtained when ENB procedures will be performed on either the "classical " endoscopic suite or in the CBCT suite

    Through study completion, an average of 1 year

Secondary Outcomes (3)

  • Rate of pneumothorax

    up to 1 month after the procedure

  • Rate of bleeding

    up to 1 month after the procedure

  • Duration of the interventions

    Up to one day after the procedure

Study Arms (2)

Endoscopy suite

ACTIVE COMPARATOR

In this arm, ENB procedure will be performed in a classical endoscopy suite equipped by a fluoroscopy.

Procedure: ENB followed by trans-bronchial biopsy and trans-bronchial cryobiopsy

CBCT suite

EXPERIMENTAL

In this arm, ENB procedure will be performed in a n hybrid room equipped by a cone beam CT (CBCT). This will allow to perform a real time visualisation of the lesion, enhanced fluoroscopy and to use the CrossCountry technique if required.

Procedure: ENB followed by trans-bronchial biopsy and trans-bronchial cryobiopsy

Interventions

After having performed the ENB procedure to reach the identified lung lesion, biopsies will be performed (six forceps trans-bronchial biopsies and one trans-bronchial lung cryobiopsy)

CBCT suiteEndoscopy suite

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pulmonary nodule of maximum 30mm of largest diameter
  • Nodules can be either solid or subsolid (including GGO) without evidence of loco-regional or distant metastasis that could be biopsied, and no evidence for an infectious underlying disease.

You may not qualify if:

  • Patient eligible for a direct surgical resection of the nodule

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Erasme

Brussels, 1070, Belgium

Location

Related Publications (1)

  • Bondue B, Taton O, Tannouri F, Van de Velde N, Remmelink M, Leduc D. High diagnostic yield of electromagnetic navigation bronchoscopy performed under cone beam CT guidance: results of a randomized Belgian monocentric study. BMC Pulm Med. 2023 May 27;23(1):185. doi: 10.1186/s12890-023-02492-7.

MeSH Terms

Conditions

Lung NeoplasmsLung Diseases

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsRespiratory Tract Diseases

Study Officials

  • Benjamin Bondue, PhD

    Erasme University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chest physician - MD PhD

Study Record Dates

First Submitted

February 8, 2022

First Posted

February 25, 2022

Study Start

February 1, 2020

Primary Completion

April 1, 2022

Study Completion

April 1, 2022

Last Updated

July 27, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will share

When published, the datasets used and/or analysed during the study will be available from the corresponding author on reasonable request.

Shared Documents
STUDY PROTOCOL, ICF, CSR
Time Frame
After the publication of the results
Access Criteria
The datasets used and/or analysed during the study will be available from the corresponding author on reasonable request.

Locations